Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 53, 944-948, March 1, 1993]
© 1993 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carmichael, P. L.
Right arrow Articles by Grover, P. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carmichael, P. L.
Right arrow Articles by Grover, P. L.

Evidence for the Involvement of a Bis-Diol-Epoxide in the Metabolic Activation of Dibenz[a,h]anthracene to DNA-binding Species in Mouse Skin1

Paul L. Carmichael2, Karl L. Platt, Meadhbh Ní Shé, Sophie Lecoq, Franz Oesch, David H. Phillips and Philip L. Grover

Institute of Cancer Resarch, Haddow Laboratories, Cotswold Road, Belmont, Sutton, Surrey, SM2 5NG, United Kingdom [P. L. C., M. N. S., S. L., D. H. P., P. L. G.], and Institute of Toxicology, University of Mainz, Obere Zahlbacher Str. 67, D-6500 Mainz, Germany [K. L. P., F. O.]

Dibenz[a,h]anthracene (DB[a,h]A) and its microsomal metabolites, trans-3,4-dihydro-3,4-dihydroxydibenz[a,h]anthracene (DBA-3,4-diol), trans, trans-3,4:8,9-tetrahydro-3,4:8,9-tetrahydroxydibenz[a,h]anthracene trans,trans-3,4:10,11-tetrahydro-3,4:10,11-tetrahydroxydibenz[a,h]anthracene (DBA-3,4,10,11-bis-diol) and trans,trans-3,4:12,13-tetrahydro-3,4:12,13-tetrahydroxydibenz[a,h]anthracene were each applied topically to mouse skin and the epidermal DNA isolated 24 h later. 32P-postlabeling analysis of each of the DNA samples was performed. DNA from mice treated with DB[a,h]A produced an adduct map on TLC consisting of one major and three minor adduct spots. A similar pattern of spots was produced by DBA-3,4-diol. No detectable DNA adducts were produced by trans,trans-3,4:12,13-tetrahydro-3,4:12,13-tetrahydroxydibenz[a,h]anthracene, although a single, minor adduct spot was produced by trans,trans-3,4:8,9-tetrahydro-3,4:8,9-tetrahydroxydibenz[a,h]-anthracene. However, DBA-3,4,10,11-bis-diol was found to produce a major single adduct that comigrated on thin layer chromatography with the major adduct produced by both DB[a,h]A and DBA-3,4-diol. In addition, this adduct was present at a level 10 times higher than the corresponding adduct produced by treatment with the parent hydrocarbon. Coelution of the major adducts formed from DB[a,h]A and DBA-3,4-diol with that formed from DBA-3,4,10,11-bis-diol was also demonstrated on reverse-phase high performance liquid chromatography. Thus, we propose that, in mouse skin, the major pathway of DB[a,h]A activation to DNA binding products is via a 3,4-diol to the 3,4,10,11-bis-diol and ultimately to a bis-diol-epoxide (potentially the 3,4,10,11-bis-dihydrodiol-1,2-oxide).

1 This work was supported, in part, by USPHS Grant CA21959, awarded by the National Cancer Institute, Department of Health and Human Services, and, in part, by grants to the Institute of Cancer Research from the Medical Research Council and the Cancer Research Campaign.

2 To whom requests for reprints should be addressed.

Received 11/17/92. Accepted 1/15/93.




This article has been cited by other articles:


Home page
Toxicol SciHome page
T. L. Weimer, A. P. Reddy, U. Harttig, D. Alexander, S. C. Stamm, M. R. Miller, W. Baird, J. Hendricks, and G. Bailey
Influence of {beta}-Naphthoflavone on 7,12-Dimethylbenz(a)anthracene Metabolism, DNA Adduction, and Tumorigenicity in Rainbow Trout
Toxicol. Sci., October 1, 2000; 57(2): 217 - 228.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Nesnow, C. Davis, W. T. Padgett, L. Adams, M. Yacopucci, and L. C. King
8,9-Dihydroxy-8,9-dihydrodibenzo[a,l]pyrene is a potent morphological cell-transforming agent in C3H10T1/2Cl8 mouse embryo fibroblasts in the absence of detectable stable covalent DNA adducts
Carcinogenesis, June 1, 2000; 21(6): 1253 - 1257.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Luch, S. Kishiyama, A. Seidel, J. Doehmer, H. Greim, and W. M. Baird
The K-Region trans-8,9-Diol Does Not Significantly Contribute as an Intermediate in the Metabolic Activation of Dibenzo[a,l]pyrene to DNA-binding Metabolites by Human Cytochrome P450 1A1 or 1B1
Cancer Res., September 1, 1999; 59(18): 4603 - 4609.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.